MYREXIS, INC.
Patent Owner
Stats
- 6 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Apr 06, 2017 most recent publication
Details
- 6 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 480 Total Citation Count
- Jun 05, 1995 Earliest Filing
- 59 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8318425 Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 proteinJul 06, 09Nov 27, 12[A61K, C12Q, A01N]
7618975 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereofJul 06, 04Nov 17, 09[A61K, A01N, C07D]
5679828 Betulinic acid and dihydrobetulinic acid derivatives and uses thereforJun 05, 95Oct 21, 97[A61K, C07C]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0029,942 COMPOUNDS AND THERAPEUTICAL USES THEREOFAbandonedOct 04, 12Jan 31, 13[A61K, C07D, A61P]
2012/0277,257 Methods of Treating Diseases, Pharmaceutical Compositions, and Pharmaceutical Dosage FormsAbandonedMay 14, 12Nov 01, 12[A61K, B29B, A61P]
2012/0238,540 AMINO-PYRIMIDINE COMPOUNDS AS INHIBITORS OF IKK EPSILON AND/OR TBK1AbandonedApr 12, 12Sep 20, 12[A61K, C07D, C12N, A61P]
2012/0214,775 Pharmaceutical Salts of 3-O-(3',3'-Dimethylsuccinyl) Betulinic AcidAbandonedApr 30, 12Aug 23, 12[A61K, A61P, C07J]
2012/0122,840 COMPOUNDS AND THERAPEUTIC USES THEREOFAbandonedSep 23, 11May 17, 12[A61K, C07D, G01N, A61P]
2011/0313,191 Preparation of Pharmaceutical Salts of 3-0-(3',3'-Dimethylsuccinyl) Betulinic AcidAbandonedJul 05, 11Dec 22, 11[C07C]
2011/0224,182 SALTS OF (3-0-(3',3'-DIMETHYLSUCCINYL) BETULINIC ACID AND SOLID STATE FORMS THEREOFAbandonedJul 17, 09Sep 15, 11[A61K, A61P, C07J]
2011/0224,240 METHODS OF TREATING CANCER AND RELATED DISEASESAbandonedJan 11, 11Sep 15, 11[A61K, A61P]
2011/0200,619 PHARMACEUTICAL COMPOUNDS AS CYTOTOXIC AGENTS AND USES THEREOFAbandonedJan 11, 11Aug 18, 11[A61K, C07D, A61P]
7989462 4-arylamin-or-4-heteroarylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereofExpiredJul 03, 07Aug 02, 11[A61K, A01N, C07D]
2011/0144,069 COMPOUNDS FOR TREATING VIRAL INFECTIONSAbandonedOct 16, 07Jun 16, 11[A61K, A61P, C07J]
7943146 Immunizing compositions comprising HIV-1 proviral constructs with an inactive p6 gag TSG101 UEV binding domain capable of producing budding-defective viral particles that remain tethered to the cell surfaceExpiredDec 20, 02May 17, 11[A61K]
7842805 Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereofExpiredJul 03, 07Nov 30, 10[A61K, C07D, A61P]
2010/0292,255 Therapeutic Compounds and Their Use in Treating Diseases and DisordersAbandonedMay 14, 10Nov 18, 10[A61K, C07D, A61P]
2010/0261,739 Method of Treating Non-Small Cell Lung CancerAbandonedFeb 16, 10Oct 14, 10[A61K, A61P]
2010/0240,630 COMPOUNDS AND THERAPEUTIC USES THEREOFAbandonedJun 04, 10Sep 23, 10[A61K, C12N, A61P, C07J]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.